1. Addition of Plerixafor to Mobilization Regimens in Autologous Peripheral Blood Stem Cell Transplants Does Not Affect the Correlation of Preharvest Hematopoietic Precursor Cell Enumeration with First-Harvest CD34+ Stem Cell Yield 
Carlos H. Villa, Tsiporah Shore, Koen Van Besien, Melissa Cushing 
Biology of Blood and Marrow Transplantation 
Volume 18, Issue 12, Pages (December 2012)
DOI: /j.bbmt
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
The relationship between first-harvest CD34+ cell yield and initial preharvest HPC count. Patients who received plerixafor are designated by open circles; those who did not receive plerixafor, by crosses. Shown are the data for all patients who received plerixafor as part of their mobilization regimens before initial harvest (A), all patients who did not receive plerixafor as part of their mobilization regimens before initial harvest (B), all patients with multiple myeloma (C), and all patients with lymphoma (D).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
ROC curves (A) and the trade-off between sensitivity and specificity of HPC count as a predictor of CD34+ cell yield <2.5 × 106 cells/kg and as a predictor of initial CD34+ cell yield >5 × 106 cells/kg (B). AUCs, shown in the inset of each ROC plot, did not differ significantly among the mobilization regimens, based on the 95% CI for each AUC.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions